跳至主要内容
临床试验/NCT03834610
NCT03834610已完成不适用

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction: A Double-blinded Randomized Controlled Clinical Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
试验地点
1
主要终点
Increase in Serum Total testosterone level in (nmol/L) after treatment.

研究概览

简要总结

Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of erection. this clinical trials compare the daily oral L-arginine plus tadalafil in treatment of erectile dysfunction in diabetic patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 56 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • patients with type 2 DM

排除标准

  • Patients with history of pelvic trauma, major pelvic surgical intervention, hypogonadism, hyperprolactinemia, hypertension, chronic prostatitis, chronic liver disease, smokers, history of chronic intake of CNS or anti-androgen drugs and patients with Peyronie's Disease or any fibrotic anomalies

研究组 & 干预措施

Group A

Active Comparator

receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: L-arginine 5 gm oral caps (Drug)

Group A

Active Comparator

receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: serum testosterone level (Diagnostic Test)

Group A

Active Comparator

receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: HbA1C (Diagnostic Test)

Group A

Active Comparator

receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: penile doppler (Device)

Group B

Active Comparator

receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: Tadalafil 10 MG (Drug)

Group B

Active Comparator

receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: serum testosterone level (Diagnostic Test)

Group B

Active Comparator

receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: HbA1C (Diagnostic Test)

Group B

Active Comparator

receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: penile doppler (Device)

Group C

Active Comparator

receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: L-arginine 5 gm oral caps (Drug)

Group C

Active Comparator

receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: Tadalafil 10 MG (Drug)

Group C

Active Comparator

receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: serum testosterone level (Diagnostic Test)

Group C

Active Comparator

receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: HbA1C (Diagnostic Test)

Group C

Active Comparator

receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: penile doppler (Device)

Group D

Placebo Comparator

receive oral methyl cellulose daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: serum testosterone level (Diagnostic Test)

Group D

Placebo Comparator

receive oral methyl cellulose daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: HbA1C (Diagnostic Test)

Group D

Placebo Comparator

receive oral methyl cellulose daily for 8 weeks serum testosterone level measurement penile doppler

干预措施: penile doppler (Device)

结局指标

主要结局

Increase in Serum Total testosterone level in (nmol/L) after treatment.

时间窗: 8 weeks of treatment

Measurement of total testosterone level in (nmol/L) improvement after treatment

Improvement in Penile Doppler parameters after treatment including peak systolic velocity in (cm/sec), end diastolic volume in (cm/sec) and resistive index (RI) that = (peak systolic velocity - end diastolic velocity ) / peak systolic velocity.

时间窗: 8 weeks of treatment

Measurement of penile doppler parameters improvement after treatment peak systolic velocity in (cm/sec), end diastolic volume in (cm/sec) and resistive index (RI).

International Index of Erectile Function score (IIEF-5) improvement after treatment. IIEF-5 score of 22-25: No erectile dysfunction (ED), 17-21: Mild ED, 12-16: Mild to moderate ED, 8-11: Moderate ED, 5-7: Severe ED.

时间窗: 8 weeks of treatment

Efficacy of oral L-arginine 5 g plus oral tadalafil 10 mg in treatment of erectile dysfunction in diabetic patients is evaluated by International Index of Erectile Function score (IIEF-5).

次要结局

未报告次要终点

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Moustafa A. El Taieb

Ass. Prof. of Dermatology, Venereology and Andrology

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验